Key result
Pretreatment with phloroglucinol (30 mg/kg) for 28 days averted isoprenaline-induced myocardial infarction in rats by reducing ECG abnormalities, cardiac marker enzymes, and lipid peroxidation.
Why the study?
The cardioprotective potential of phloroglucinol against isoprenaline hydrochloride-induced myocardial infarction in rats was assessed.
Does pretreatment with phloroglucinol prevent isoprenaline-induced myocardial infarction in rats?
Population
Rats
Comparison
Phloroglucinol pretreatment (30 mg/kg) followed by isoprenaline hydrochloride vs isoprenaline alone
Design
Animal experimental study
Authors
Loading...
Phloroglucinol pretreatment attenuated injury in this rat model; hypothesis-generating and should not yet inform clinical practice.
Does pretreatment with phloroglucinol prevent isoprenaline-induced myocardial infarction in rats?
Phloroglucinol pretreatment demonstrates cardioprotective effects against isoprenaline-induced myocardial infarction in a rat model.
Zhu et al. (2019) studied Myocardial infarction. Phloroglucinol (PG) vs. Isoprenaline alone treated group was evaluated on Abnormalities in ECG patterns, cardiac marker enzymes, antioxidants, lipid peroxidation, lipid profiles, and histopathology. Pretreatment with phloroglucinol (30 mg/kg) for 28 days averted isoprenaline-induced myocardial infarction in rats by reducing ECG abnormalities, cardiac marker enzymes, and lipid peroxidation.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: